APPLICATION
ANDA203963
TYPE
ANDA
ORIGINAL APPROVAL
2015-11-18
LATEST ACTION
2025-03-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
SILDENAFIL CITRATEPrescription
SILDENAFIL CITRATE EQ 20MG BASE · TABLET · ORAL
Approval history
2025-03-18Labeling · Supplement 12 · standardAP
2020-02-21Labeling · Supplement 3 · standardAP
2020-02-21Labeling · Supplement 4 · standardAP
2020-02-21Labeling · Supplement 2 · standardAP
2015-11-18UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.